10 Surprising Twists in CBD and Cannabis in 2020

10 Surprising Twists in CBD and Cannabis in 2020

10 Surprising Twists in CBD and Cannabis

Cannabidiol (CBD) products came to store shelves last year in a hail of uncertainty.

10 Surprising Twists in CBD and Cannabis in 2020

3. Testing Woes

The FDA’s July 9 testing report documented lab testing of CBD products between 2014 and 2020.

In a channel where consumers spend an average of three to four minutes in the store—and only 21 seconds at checkout, per NACS data—education of a complex new category was always going to be a challenge

CBD manufacturers are prohibited from making any form of health claims, but that hasn’t stopped consumers from educating themselves on the positive effects

When asked to name the biggest twist of 2020, Lukas didn’t cite COVID-19 or the recession

When examining the FDA’s testing report, something else stood out to Havens.

Though the mainstream CBD industry is still in its infancy, M&A activity is already picking up.

In 2020, the second-largest Convenience retailer in the United States made good on its vow to be one of the “key players” in the North American recreational cannabis market

According to IRI data through June 2020, mainstream retail CBD sales were up 89% year over year

Another set of trends emerging from the dispensary channel: infused beverages and smokeable products.

  • Page 1